Amedisys Inc (AMED)
Total asset turnover
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (ttm) | US$ in thousands | 2,348,324 | 2,321,060 | 2,289,626 | 2,251,407 | 2,236,382 | 2,227,658 | 2,229,409 | 2,234,331 | 2,223,199 | 2,220,452 | 2,215,949 | 2,222,225 | 2,214,112 | 2,205,500 | 2,196,085 | 2,116,978 | 2,071,519 | 2,021,492 | 1,972,053 | 1,979,978 |
| Total assets | US$ in thousands | 2,138,710 | 2,139,110 | 2,117,370 | 2,089,870 | 2,060,170 | 2,027,420 | 1,982,400 | 1,946,960 | 1,976,240 | 1,982,130 | 2,000,990 | 1,908,390 | 1,856,970 | 1,937,640 | 1,599,560 | 1,573,210 | 1,567,200 | 1,602,720 | 1,645,490 | 1,440,080 |
| Total asset turnover | 1.10 | 1.09 | 1.08 | 1.08 | 1.09 | 1.10 | 1.12 | 1.15 | 1.12 | 1.12 | 1.11 | 1.16 | 1.19 | 1.14 | 1.37 | 1.35 | 1.32 | 1.26 | 1.20 | 1.37 |
December 31, 2024 calculation
Total asset turnover = Revenue (ttm) ÷ Total assets
= $2,348,324K ÷ $2,138,710K
= 1.10
The total asset turnover of Amedisys Inc has been fluctuating over the past few years, ranging from 1.08 to 1.37. This ratio measures the efficiency of the company in generating revenue from its assets, with a higher ratio indicating better asset utilization.
From March 31, 2020, to September 30, 2021, the total asset turnover showed a general increasing trend, reaching its peak at 1.37 on June 30, 2021. However, starting from September 30, 2021, the ratio began to decline and fluctuate within a narrower range between 1.09 and 1.16 up to December 31, 2024.
The slight decrease in total asset turnover from its peak suggests that Amedisys Inc may have experienced challenges in effectively leveraging its assets to generate revenue in recent years. This trend would be important for investors and stakeholders to monitor, as it may indicate changes in the company's operational efficiency and overall financial performance.
Peer comparison
Dec 31, 2024